☆ 4.7 Editorial Material

A combination of immunoadjuvant nanocomplexes and dendritic cell vaccines in the presence of immune checkpoint blockade for effective cancer immunotherapy

CELLULAR & MOLECULAR IMMUNOLOGY (2021)

Potent anti-myeloma efficacy of dendritic cell therapy in combination with pomalidomide and programmed death-ligand 1 blockade in a preclinical model of multiple myeloma

Tan-Huy Chu et al.

Summary: The study demonstrates that combining DC vaccine, pomalidomide, and PD-L1 blockade can inhibit tumor growth in a multiple myeloma mouse model. It also enhances the proportions of immune effector cells in the spleen and tumor microenvironment, as well as improves the functional activities of cytotoxic T lymphocytes and NK cells in the spleen.

CANCER IMMUNOLOGY IMMUNOTHERAPY (2021)

添加到收藏夹

Article Multidisciplinary Sciences

Immunostimulatory nanomedicines synergize with checkpoint blockade immunotherapy to eradicate colorectal tumors

Xiaopin Duan et al.

NATURE COMMUNICATIONS (2019)

添加到收藏夹

Article Immunology

Lenalidomide and Programmed Death-1 Blockade Synergistically Enhances the Effects of Dendritic Cell Vaccination in a Model of Murine Myeloma

Manh-Cuong Vo et al.

FRONTIERS IN IMMUNOLOGY (2018)

添加到收藏夹

Article Polymer Science

Self-Assembled, Adjuvant/Antigen-Based Nanovaccine Mediates Anti-Tumor Immune Response against Melanoma Tumor

Santhosh Kalash Rajendrakumar et al.

POLYMERS (2018)

添加到收藏夹

Review Chemistry, Multidisciplinary

Nanoparticle-Based Manipulation of Antigen-Presenting Cells for Cancer Immunotherapy

Ronnie H. Fang et al.

SMALL (2015)

添加到收藏夹

Review Chemistry, Multidisciplinary

Nanoparticle-Based Immunotherapy for Cancer

Kun Shao et al.

ACS NANO (2015)

添加到收藏夹

A combination of immunoadjuvant nanocomplexes and dendritic cell vaccines in the presence of immune checkpoint blockade for effective cancer immunotherapy

相关参考文献

Potent anti-myeloma efficacy of dendritic cell therapy in combination with pomalidomide and programmed death-ligand 1 blockade in a preclinical model of multiple myeloma

Immunostimulatory nanomedicines synergize with checkpoint blockade immunotherapy to eradicate colorectal tumors

Lenalidomide and Programmed Death-1 Blockade Synergistically Enhances the Effects of Dendritic Cell Vaccination in a Model of Murine Myeloma

Self-Assembled, Adjuvant/Antigen-Based Nanovaccine Mediates Anti-Tumor Immune Response against Melanoma Tumor

Nanoparticle-Based Manipulation of Antigen-Presenting Cells for Cancer Immunotherapy

Nanoparticle-Based Immunotherapy for Cancer

导出引文

分享论文